Ubs Asset Management Americas Inc Roivant Sciences Ltd. Put Options Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$692 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$653 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$503 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$372 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.41B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...